Search Results - "Mega, William"
-
1
Integrative Omic Analysis of Experimental Bacteremia Identifies a Metabolic Signature That Distinguishes Human Sepsis from Systemic Inflammatory Response Syndromes
Published in American journal of respiratory and critical care medicine (15-08-2014)“…Sepsis is a leading cause of morbidity and mortality. Currently, early diagnosis and the progression of the disease are difficult to make. The integration of…”
Get full text
Journal Article -
2
Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection
Published in PloS one (24-07-2015)“…Protective antigen (PA), one of the components of the anthrax toxin, is the major component of human anthrax vaccine (Biothrax). Human anthrax vaccines…”
Get full text
Journal Article -
3
Plazomicin is effective in a non-human primate pneumonic plague model
Published in Bioorganic & medicinal chemistry (15-12-2016)“…[Display omitted] The efficacy of plazomicin for pneumonic plague was evaluated in a non-human primate model. African Green monkeys challenged with a lethal…”
Get full text
Journal Article -
4
Levofloxacin cures experimental pneumonic plague in African green monkeys
Published in PLoS neglected tropical diseases (08-02-2011)“…Yersinia pestis, the agent of plague, is considered a potential bioweapon due to rapid lethality when delivered as an aerosol. Levofloxacin was tested for…”
Get full text
Journal Article -
5
A chimeric Sindbis-based vaccine protects cynomolgus macaques against a lethal aerosol challenge of eastern equine encephalitis virus
Published in Vaccine (01-03-2013)“…Highlights ► Chimeric vaccines were constructed from a cDNA clone containing genes from divergent EEE strains. ► The immunogenicity of each of the vaccines…”
Get full text
Journal Article -
6
-
7
Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V)
Published in Vaccine (16-11-2010)“…Abstract Passive transfer models were developed to evaluate the ability of antibodies generated in cynomolgus macaques and humans vaccinated with a recombinant…”
Get full text
Journal Article -
8
Telemetry use in infectious disease/biodefense: Biomarkers for model development and efficacy evaluation
Published in Journal of pharmacological and toxicological methods (01-07-2011)Get full text
Journal Article -
9
Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection: e0130952
Published in PloS one (01-07-2015)“…Protective antigen (PA), one of the components of the anthrax toxin, is the major component of human anthrax vaccine (Biothrax). Human anthrax vaccines…”
Get full text
Journal Article